A citation-based method for searching scientific literature

Li Guo, Eduardo M Normando, Parth Arvind Shah, Lies De Groef, M Francesca Cordeiro. Mov Disord 2018
Times Cited: 23







List of co-cited articles
181 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Visual dysfunction in Parkinson's disease.
Rimona S Weil, Anette E Schrag, Jason D Warren, Sebastian J Crutch, Andrew J Lees, Huw R Morris. Brain 2016
138
43

The retina in Parkinson's disease.
Neil K Archibald, Michael P Clarke, Urs P Mosimann, David J Burn. Brain 2009
207
43

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
43
34

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
Thomas G Beach, Jeremiah Carew, Geidy Serrano, Charles H Adler, Holly A Shill, Lucia I Sue, Marwan N Sabbagh, Haruhiko Akiyama, Nicolás Cuenca. Neurosci Lett 2014
70
30

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.
Merel S Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R Bloem. Parkinsonism Relat Disord 2017
37
30

Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
Neil K Archibald, Mike P Clarke, Urs P Mosimann, David J Burn. Mov Disord 2011
100
26

Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
Nico J Diederich, Rema Raman, Sue Leurgans, Christopher G Goetz. Arch Neurol 2002
87
26

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
232
26

Ophthalmological features of Parkinson disease.
Barbara Nowacka, Wojciech Lubinski, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Med Sci Monit 2014
50
26

Retinal nerve fiber layer thinning in Parkinson disease.
Rivka Inzelberg, Jose Antonio Ramirez, Puiu Nisipeanu, Avinoam Ophir. Vision Res 2004
211
26

Decreased color discrimination and contrast sensitivity in Parkinson's disease.
V Pieri, N J Diederich, R Raman, C G Goetz. J Neurol Sci 2000
98
26

Oculo-Visual Dysfunction in Parkinson's Disease.
R A Armstrong. J Parkinsons Dis 2015
45
21

Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.
Hideaki Matsui, Fukashi Udaka, Akiko Tamura, Masaya Oda, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama. J Geriatr Psychiatry Neurol 2006
58
21

Venturing into the no-man's land of the retina in Parkinson's disease.
Ivan Bodis-Wollner, Shahnaz Miri, Sofya Glazman. Mov Disord 2014
43
21

α-synuclein in the inner retina in parkinson disease.
Ivan Bodis-Wollner, Piotr B Kozlowski, Sofya Glazman, Shahnaz Miri. Ann Neurol 2014
84
21

Retinal changes in Parkinson's disease and glaucoma.
Juliane Matlach, Martin Wagner, Uwe Malzahn, Irene Schmidtmann, Frank Steigerwald, Thomas Musacchio, Jens Volkmann, Franz Grehn, Winfried Göbel, Stephan Klebe. Parkinsonism Relat Disord 2018
15
33

Dopamine and retinal function.
Paul Witkovsky. Doc Ophthalmol 2004
484
21

Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
Marilita M Moschos, Georgios Tagaris, Ioannis Markopoulos, Ioannis Margetis, Stylianos Tsapakis, Menelaos Kanakis, Chrysanthi Koutsandrea. Eur J Ophthalmol 2011
101
21

Ophthalmologic features of Parkinson's disease.
V Biousse, B C Skibell, R L Watts, D N Loupe, C Drews-Botsch, N J Newman. Neurology 2004
129
21

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.
A Ridder, M L T M Müller, V Kotagal, K A Frey, R L Albin, N I Bohnen. Parkinsonism Relat Disord 2017
20
25

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Christopher R Adam, Eric Shrier, Yin Ding, Sofya Glazman, Ivan Bodis-Wollner. J Neuroophthalmol 2013
55
17

Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Josie-Anne Bertrand, Christophe Bedetti, Ronald B Postuma, Oury Monchi, Daphné Génier Marchand, Thomas Jubault, Jean-François Gagnon. Mov Disord 2012
49
17

The retina as a window to the brain-from eye research to CNS disorders.
Anat London, Inbal Benhar, Michal Schwartz. Nat Rev Neurol 2013
374
17

Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics.
T Langheinrich, L Tebartz van Elst, W A Lagrèze, M Bach, C H Lücking, M W Greenlee. Clin Neurophysiol 2000
53
17

Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity.
I Bodis-Wollner, M S Marx, S Mitra, P Bobak, L Mylin, M Yahr. Brain 1987
225
17

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
17

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim. Mov Disord 2014
62
17

Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
M J Price, R G Feldman, D Adelberg, H Kayne. Neurology 1992
166
17

Remodeling of the fovea in Parkinson disease.
B Spund, Y Ding, T Liu, I Selesnick, S Glazman, E M Shrier, I Bodis-Wollner. J Neural Transm (Vienna) 2013
51
17

Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?
C La Morgia, P Barboni, G Rizzo, M Carbonelli, G Savini, C Scaglione, S Capellari, S Bonazza, M P Giannoccaro, G Calandra-Buonaura,[...]. Eur J Neurol 2013
68
17

Early ophthalmologic features of Parkinson's disease: a review of preceding clinical and diagnostic markers.
Pierpaolo Turcano, John J Chen, Britta L Bureau, Rodolfo Savica. J Neurol 2019
7
57

Impairment of high-contrast visual acuity in Parkinson's disease.
R D Jones, I M Donaldson, P L Timmings. Mov Disord 1992
49
17

MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells.
W G Tatton, M M Kwan, M C Verrier, N A Seniuk, E Theriault. Brain Res 1990
75
17

Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.
Julián Esteve-Rudd, Laura Fernández-Sánchez, Pedro Lax, Emilio De Juan, José Martín-Nieto, Nicolás Cuenca. Neurobiol Dis 2011
32
17

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
V Polo, M Satue, M J Rodrigo, S Otin, R Alarcia, M P Bambo, M I Fuertes, J M Larrosa, L E Pablo, E Garcia-Martin. BMJ Open 2016
35
17


A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Shahnaz Miri, Sofya Glazman, Leland Mylin, Ivan Bodis-Wollner. Parkinsonism Relat Disord 2016
27
17


Retinal nerve fiber layer thickness in Parkinson disease.
Serkan Kirbas, Kemal Turkyilmaz, Ahmet Tufekci, Mustafa Durmus. J Neuroophthalmol 2013
62
17

Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.
C Bulens, J D Meerwaldt, G J Van der Wildt, J B Van Deursen. Ann Neurol 1987
74
17

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
17

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
17

Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
M F Silva, P Faria, F S Regateiro, V Forjaz, C Januário, A Freire, M Castelo-Branco. Brain 2005
86
13

Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.
Isabel Ortuño-Lizarán, Gema Esquiva, Thomas G Beach, Geidy E Serrano, Charles H Adler, Pedro Lax, Nicolás Cuenca. Acta Neuropathol Commun 2018
19
15

Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
Jee-Young Lee, Jeeyun Ahn, Tae Wan Kim, Beom Seok Jeon. J Parkinsons Dis 2014
45
13


The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Eduardo Maria Normando, Benjamin Michael Davis, Lies De Groef, Shereen Nizari, Lisa A Turner, Nivedita Ravindran, Milena Pahlitzsch, Jonathan Brenton, Giulia Malaguarnera, Li Guo,[...]. Acta Neuropathol Commun 2016
48
13

Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
Nicolás Cuenca, María-Trinidad Herrero, Antonia Angulo, Emilio de Juan, Gema C Martínez-Navarrete, Salvador López, Carlos Barcia, José Martín-Nieto. J Comp Neurol 2005
40
13

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.
Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stephane Hunot, Andrew Singleton, C Warren Olanow, Kalpana M Merchant, Erwan Bezard,[...]. Lancet Neurol 2015
221
13

Visual symptoms in Parkinson's disease.
R A Armstrong. Parkinsons Dis 2011
80
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.